Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy
Ankylosing spondylitis (AS) is a chronic, inflammatory rheumatic disease that has a highly variable disease course. Three biologic agents, adalimumab, etanercept, and infliximab, have been developed for the treatment of AS. We conducted three studies: 1) an exploratory analysis of a year-long longit...
Main Author: | Maxwell, Lara J |
---|---|
Language: | en |
Published: |
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/20093 |
Similar Items
-
Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy
by: Maxwell, Lara J
Published: (2011) -
Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy
by: Maxwell, Lara J
Published: (2011) -
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs
by: F.M. Perrotta, et al.
Published: (2014-11-01) -
EFFICACY DIFFERENCES BETWEEN CLASSICAL AND BIOLOGICAL TREATMENT IN ANKYLOSING SPONDYLITIS
by: Claudiu Popescu, et al.
Published: (2016-09-01) -
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
by: Bahar Say, et al.
Published: (2019-09-01)